LKB1
Showing 1 - 25 of 50
NSCLC With STK11/LKB1 Mutation Trial in New York (Daratumumab and Hyaluronidase-fihj, Pre-Intervention Medication,
Not yet recruiting
- Non-small Cell Lung Cancer With STK11/LKB1 Mutation
- Daratumumab and Hyaluronidase-fihj
- +2 more
-
New York, New YorkNYU Langone Health
Mar 29, 2023
Advanced LKB1-inactive Lung Adenocarcinoma Trial in Milan (Metformin Hydrochloride, Cisplatin, Carboplatin)
Recruiting
- Advanced LKB1-inactive Lung Adenocarcinoma
- Metformin Hydrochloride
- +5 more
-
Milan, ItalyMarina Chiara Garassino
Nov 12, 2020
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, NF1 Mutation Positive Malignant Peripheral Nerve Sheath Tumor
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +3 more
- Pharmacodynamic Study
- Telaglenastat Hydrochloride
-
Birmingham, Alabama
- +30 more
Sep 1, 2022
Lung Cancer Trial in Houston (Cemiplimab, Kevzara (Sarilumab))
Not yet recruiting
- Lung Cancer
- Cemiplimab
- Kevzara (Sarilumab)
-
Houston, TexasM D Anderson Cancer Center
Jan 19, 2023
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in
Recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +4 more
- Adenosine A2B Receptor Antagonist PBF-1129
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Feb 1, 2023
NSCLC (NSCLC) Colorectal Cancer (CRC) Pancreatic Ductal Adenocarcinoma Advanced Solid Tumors Trial in Irving, San Antonio,
Not yet recruiting
- Non-Small Cell Lung Cancer (NSCLC) Colorectal Cancer (CRC) Pancreatic Ductal Adenocarcinoma Advanced Solid Tumors
- Assigned interventions
-
Irving, Texas
- +2 more
Nov 7, 2023
NSCLC, Non-squamous Non-small-cell Lung Cancer, Non-Squamous Non-Small Cell Tumor of Lung Trial in United States (drug,
Terminated
- Non-Small Cell Lung Cancer
- +5 more
- Telaglenastat
- +7 more
-
Birmingham, Alabama
- +101 more
Mar 8, 2022
Breast Cancer Female Trial (VTM examination and breast biopsy)
Not yet recruiting
- Breast Cancer Female
- VTM examination and breast biopsy
- (no location specified)
Sep 23, 2023
NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma Trial in Nashville, San Antonio, Fairfax (RMC-6291)
Recruiting
- Non-Small Cell Lung Cancer (NSCLC)
- +3 more
-
San Antonio, Texas
- +1 more
Aug 16, 2022
Non Small Cell Lung Cancer, Solid Tumors, Adult, Endometrial Cancer Trial in Fairfax (TNG260, Pembrolizumab)
Recruiting
- Non Small Cell Lung Cancer
- +6 more
-
Fairfax, VirginiaNEXT Oncology
Jun 7, 2023
Well Differentiated Pancreatic Endocrine Tumor Trial in Milano (Everolimus plus Octreotide LAR plus Metformin)
Active, not recruiting
- Well Differentiated Pancreatic Endocrine Tumor
- Everolimus plus Octreotide LAR plus Metformin
-
Milano, ItalyFondazione IRCCS Istituto Tumori Milano
Sep 3, 2021
Metastatic Lung Cancer Trial in France (InvisionFirst® molecular panel)
Active, not recruiting
- Metastatic Lung Cancer
- InvisionFirst® molecular panel
-
Bayeux, France
- +15 more
Aug 22, 2022
KRAS Gene Mutation, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7 Trial in United States
Active, not recruiting
- KRAS Gene Mutation
- +2 more
- Docetaxel
- +2 more
-
Anchorage, Alaska
- +604 more
Jan 28, 2023
Becker Muscular Dystrophy Trial in Sacramento ((-)-epicatechin)
Completed
- Becker Muscular Dystrophy
-
Sacramento, CaliforniaUniversity of California, Davis
Nov 22, 2021
EGFR Mutation Positive Non Small Cell Lung Cancer Trial in Sutton
Active, not recruiting
- EGFR Mutation Positive Non Small Cell Lung Cancer
-
Sutton, United KingdomRoyal Marsden
Mar 5, 2021
Reperfusion Injury, Vascular Complications Trial in Vienna (Dapagliflozin 10mg, Placebo)
Recruiting
- Reperfusion Injury
- Vascular Complications
- Dapagliflozin 10mg
- Placebo
-
Vienna, AustriaMedical University of Vienna
Feb 15, 2022
NSCLC, Non-squamous Non-small-cell Lung Cancer, Non-Squamous Non-Small Cell Tumor of Lung Trial in United States (Liquid Biopsy
Active, not recruiting
- Non-Small Cell Lung Cancer
- +5 more
- Liquid Biopsy NGS Test
-
Daphne, Alabama
- +62 more
Nov 5, 2021
Non Small Cell Lung Cancer Trial in Mexico City (Metformin Hydrochloride, Placebo)
Recruiting
- Non Small Cell Lung Cancer
- Metformin Hydrochloride
- Placebo
-
Mexico City, MexicoInstituto Nacional de Cancerologia
Jul 21, 2022
Neuroendocrine Tumors Trial in Milan (Lanreotide and Metformin)
Active, not recruiting
- Neuroendocrine Tumors
- Lanreotide and Metformin
-
Milan, ItalyNationalCIMilan
Jun 4, 2021
Novel Genetic Factors That Contribute to Risk for Breast Cancer
Active, not recruiting
- Invasive Breast Cancer
-
Columbus, OhioThe Ohio State University
Feb 2, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Mexico City (Metformin Glycinate, Placebo oral tablet)
Completed
- Severe Acute Respiratory Syndrome Coronavirus 2
- Metformin Glycinate
- Placebo oral tablet
-
Mexico City, MexicoThe American British Cowdray Medical Center, I.A.P
Apr 5, 2021
Malnutrition, Loneliness Trial in Ithaca (VideoDine)
Completed
- Malnutrition
- Loneliness
- VideoDine
-
Ithaca, New YorkCornell University
Sep 23, 2022
Severe Acute Respiratory Syndrome Coronavirus 2, Metabolic Syndrome, Type 2 Diabetes Trial in Mexico City (metformin glycinate,
Withdrawn
- Severe Acute Respiratory Syndrome Coronavirus 2
- +2 more
- metformin glycinate
- Placebo oral tablet
-
Mexico City, MexicoHospital Juárez de México, OPD
Apr 5, 2021